On the evening of November 2, 2018, Imexpharm was honored to earn a prestigious "double win" with awards for First Place for Best Corporate Governance and Third Place for Best Annual Report in the medium-cap group. The accolades were announced at the 2018 Vietnam Listed Company Awards Ceremony, held on the evening of November 2, 2018, in grand style at The Reverie Saigon Hotel. Co-organized by the Ho Chi Minh Stock Exchange (HOSE), Hanoi Stock Exchange (HNX), Đầu tư Chứng khoán newspaper, and Dragon Capital, the annual event recognizes excellence in transparency, corporate governance, and sustainable development among listed companies.
The Vietnam Listed Company Awards (VLCA), formerly known as the Vietnam Annual Report Awards (ARA), has been revamped to enhance both the depth and breadth of its quality. It aims to continue supporting and encouraging listed companies to operate with transparency, effective governance, and sustainable development.
This annual event has accompanied the Vietnamese stock market for over a decade, continuously improved and professionalized. It has become a prestigious and high-quality benchmark, providing reliable information and data for domestic and international investors, as well as shareholders seeking trustworthy insights into listed companies.
Understanding and adhering to the criteria carefully crafted by the organizers, Imexpharm recognizes the expectations and aspirations of investors and partners. The company has demonstrated professionalism and commitment in producing its annual reports and sustainability reports, ensuring transparency in information related to business operations, social and environmental activities, and community engagement.
As a result, Imexpharm has consistently invested in and approached this category with seriousness and meticulousness. Over the years, Imexpharm has frequently been recognized among the top-rated listed companies. This reflects its dedication to meeting investor expectations and its aspiration to continuously improve, transforming transparency into a tradition and cultural hallmark of the company. This commitment demonstrates absolute respect and transparency toward shareholders and investors.
The 2018 awards introduced changes by categorizing companies based on their market capitalization, large, medium, and small, which allowed for more precise evaluation and recognition. This year, Imexpharm proudly received two awards: First Place for Best Corporate Governance and Third Place for Best Annual Report in the medium-cap group. These achievements underscore the collective efforts of Imexpharm’s Board of Directors, Executive Management Team, and all employees.
Imexpharm’s 2017 Annual Report, titled “Hội Tụ Tỏa Sáng” (Converging Brilliance), embodies the idea that the company is a worthy place for talented and dedicated individuals to contribute and collaborate long-term. It reflects not only a convergence of human capital but also cutting-edge science and technology, coupled with some of the most advanced manufacturing facilities in Vietnam and the region. For these reasons, Imexpharm remains a trusted destination for investors and shareholders, fostering a powerful energy that breaks through all barriers to achieve success.